Delta Air Lines, Inc. vs IDEXX Laboratories, Inc. — how do they compare? Delta Air Lines, Inc. trades at $90.99 (market cap $59.46B), while IDEXX Laboratories, Inc. trades at $589.8 (market cap $46.22B). The key difference: Delta Air Lines, Inc. is the larger of the two by market cap, and Delta Air Lines, Inc. pays a 0.86% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| DAL | IDXX | |
|---|---|---|
Market Cap | $59.46B | $46.22B |
Sector | Industrials | Health |
52-Week High | $93.66 | $766.68 |
52-Week Low | $55.65 | $526.44 |
Enterprise Value | $74.77B | $47.12B |
Dividend Yield | 0.86% | — |
Signals from Pluang's Aura AI — not financial advice
Delta Air Lines (DAL) trades at $89.21, down 2.33% on the day, amid strong fundamental performance with three consecutive quarterly earnings beats. The stock maintains attractive valuation metrics including a P/E of 14.99 and P/S of 0.87, while showing robust profitability with 20.12% ROE. Technical indicators suggest a bullish trend with current price near key support at $89. Recent corporate developments include dividend payments and strong cash flow generation of $1.08 billion in 2025.
DAL presents a compelling investment case with strong analyst support (82% buy ratings) and a $108.27 consensus price target implying 21% upside. The airline benefits from premium travel demand and lucrative loyalty partnerships, though faces headwinds from fuel cost volatility and competitive pressures. Earnings momentum remains positive with Q3 2026 expectations of $2.19 EPS.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.
Read more on DAL →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →